BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioGaia AB Interim Report 1 January – 30 September 2012


10/23/2012 9:10:38 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

BioGaia: (STO:BIOG)

1 January – 30 September 2012

- Net sales reached SEK 572.8 million (232.6). This figure includes licence revenue of SEK 356.0 million from Nestlé that is regarded as non-recurring revenue but is to a certain extent attributable to sales in 2012. Excluding license revenue from Nestlé, net sales amounted to SEK 216.8 million (232.6), a decrease of SEK 15.8 million (-7%). (Excluding foreign exchange effects, the decrease was 6%).

- Net sales of finished consumer products amounted to SEK 172.0 million (158.0), an increase of SEK 14.0 million (9%). Excluding foreign exchange effects, net sales rose by 10%.

- Net sales of component products totalled SEK 399.8 million (73.2). Excluding license revenue from Nestlé, net sales of component products reached SEK 43.8 million (73.2), a decrease of SEK 29.4 million (-40%) which is a result of the earlier agreement with Nestlé (see above).

- Operating profit was SEK 414.9 million (79.4), an improvement of SEK 335.5 million. Excluding license revenue from Nestlé, operating profit was SEK 58.9 million (79.4), down by SEK 20.5 million (-26%). (Excluding foreign exchange effects, the decrease was 22%).

- Profit after tax was SEK 314.1 million (57.8). Excluding license revenue, profit after tax was SEK 51.7 million (57.8), a decrease of SEK 6.1 million (-11%).



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES